Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1
Clinical trial NCT03721679 · TERMINATED
Trial details
- NCT number
- NCT03721679
- Sponsor
- Oncovir, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2021-01-26
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.